Stephen W. Webster - 08 Jun 2023 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Director
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
08 Jun 2023
Transactions value $
$0
Form type
4
Date filed
12 Jun 2023, 17:51
Previous filing
01 Jun 2023
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Stock Option (Right to Buy) Award $0 +18.5K $0.00 18.5K 08 Jun 2023 Common Stock 18.5K $13.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option represents a right to purchase a total of 18,450 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 8, 2024 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.